
iRhythm Technologies (IRTC) Stock Forecast & Price Target
iRhythm Technologies (IRTC) Analyst Ratings
Bulls say
iRhythm Holdings Inc. reported a gross margin of 71.1%, an increase of 230 basis points year-over-year, which surpassed consensus estimates and indicates strong operational efficiency. The company anticipates a revenue outlook of $870-$880 million for 2025, reflecting a year-over-year growth of 16-18%, driven by robust performances in its ZIO systems and strong pricing mix. Additionally, iRhythm is expected to see notable improvements in EBITDA margins, projecting around 400 basis points of annual enhancement, which suggests strong potential for profitability and continued growth in the digital healthcare market.
Bears say
iRhythm Holdings Inc. faces significant challenges that contribute to a negative outlook, including expectations of slowing growth projected to reach only the low-teens and sluggish profitability improvements. The company's pricing is anticipated to remain flat through 2026 amid competitive pressures and risks associated with commercial reimbursement rates, which may be negatively impacted by broader market dynamics in the extended-wear cardiac monitoring sector. Additionally, iRhythm's adjusted operating expenses, despite a slight year-over-year decrease, include substantial investment in research and development, highlighting the financial strain from the need to innovate while navigating increasing competition and potential sales execution problems.
This aggregate rating is based on analysts' research of iRhythm Technologies and is not a guaranteed prediction by Public.com or investment advice.
iRhythm Technologies (IRTC) Analyst Forecast & Price Prediction
Start investing in iRhythm Technologies (IRTC)
Order type
Buy in
Order amount
Est. shares
0 shares